Tuberculosis is the most important single cause of infectious disease
in the world today, causing 8 million new cases and 3 million deaths a
nnually. Almost one third of the world's population is infected with t
he causative organism, Mycobacterium tuberculosis, The declining trend
in cases ceased or reversed in the developed and parts of the develop
ing world during the 1980s. In most developing countries, especially i
n Africa and Asia, the trend continues to deteriorate due to failure t
o give priority to, or poorly organized, programs with low case findin
g and cure, lack of international donors support, coinfection with the
human immunodeficiency virus (HIV), increasing homelessness, and incr
easing institutional outbreaks. Although modern short course combinati
on chemotherapy is highly effective, mortality rates remain high in th
ese areas. Drug resistance, particularly resistance to isoniazid and r
ifampin (MDR-TB), poses a significant problem to control programs but
with some exceptions has not been surveyed systematically; the WHO/IUA
TLD Global Surveillance Project was established to address this defici
ency and its role is as described.